Chlamydial infection increases gonococcal colonization in a novel murine coinfection model

Infection and Immunity

Volumn 79, Issue 4, 2011, Pages 1566-1577

  Vonck, Rachel A ^a   Darville, T ^b   O'Connell, C M ^b   Jerse, Ann E ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GONORRHEA; INNATE IMMUNITY; MIXED INFECTION; MOUSE; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GONORRHEA; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; NEISSERIA GONORRHOEAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79953313415     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01155-10     Document Type: Article

References (86)

1. Abdelrahman, Y. M., and R. J. Belland. 2005. The chlamydial developmental cycle. FEMS Microbiol. Rev. 29:949-959.
2. Agrawal, T., V. Vats, S. Salhan, and A. Mittal. 2009. Determination of chlamydial load and immune parameters in asymptomatic, symptomatic and infertile women. FEMS Immunol. Med. Microbiol. 55:250-257.
3. Barron, A. L., H. J. White, R. G. Rank, B. L. Soloff, and E. B. Moses. 1981. A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis. J. Infect. Dis. 143:63-66.
4. Batteiger, B. E., J. Fraiz, W. J. Newhall, B. P. Katz, and R. B. Jones. 1989. Association of recurrent chlamydial infection with gonorrhea. J. Infect. Dis. 159:661-669.
5. Belay, T., et al. 2002. Chemokine and chemokine receptor dynamics during genital chlamydial infection. Infect. Immun. 70:844-850.
6. Berti, M., G. P. Candiani, and V. Arioli. 1989. A new mouse model of Chlamydia trachomatis MoPn genital infection. J. Chemother. 1:44-45.
7. Brodeur, B. R., et al. 1985. Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody. Infect. Immun. 50:510-516.
8. Caldwell, H. D., J. Kromhout, and J. Schachter. 1981. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 31:1161-1176.
9. Centers for Disease Control and Prevention. 2008. 2006 disease profile. Centers for Disease Control and Prevention, Atlanta, GA.
10. Centers for Disease Control and Prevention. 2002. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm. Rep. 51:1-78.
11. Cohen, M. S., and J. G. Cannon. 1999. Human experimentation with Neisseria gonorrhoeae: progress and goals. J. Infect. Dis. 179(Suppl. 2):S375- S379.
12. Cohen, M. S., et al. 1994. Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development. J. Infect. Dis. 169:532-537.
13. Cole, J. G., N. B. Fulcher, and A. E. Jerse. Opacity proteins increase Neisseria gonorrhoeae fitness in the female genital tract due to a factor under ovarian control. Infect. Immun. 78:1629-1641.
14. Cornelissen, C. N., G. D. Biswas, and P. F. Sparling. 1993. Expression of gonococcal transferrin-binding protein 1 causes Escherichia coli to bind human transferrin. J. Bacteriol. 175:2448-2450.
15. Dalal, S. J., J. S. Estep, I. E. Valentin-Bon, and A. E. Jerse. 2001. Standardization of the Whitten Effect to induce susceptibility to Neisseria gonorrhoeae in female mice. Contemp. Top. Lab. Anim. Sci. 40:13-17.
16. Darville, T., et al. 1997. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect. Immun. 65:3065-3073.
17. Darville, T., C. W. Andrews, Jr, J. D. Sikes, P. L. Fraley, and R. G. Rank. 2001. Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection. Infect. Immun. 69:3556-3561.
18. Dehio, C., S. D. Gray-Owen, and T. F. Meyer. 2000. Host cell invasion by pathogenic neisseriae. Subcell. Biochem. 33:61-96.
19. de la Maza, L. M., S. Pal, A. Khamesipour, and E. M. Peterson. 1994. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect. Immun. 62:2094-2097.
20. Dicker, L. W., D. J. Mosure, S. M. Berman, and W. C. Levine. 2003. Gonorrhea prevalence and coinfection with chlamydia in women in the United States, 2000. Sex. Transm. Dis. 30:472-476.
21. Draper, D. L., et al. 2000. Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am. J. Obstet. Gynecol. 183:1243-1248.
22. Duncan, J. A., et al. 2009. Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASCcontaining inflammasome. J. Immunol. 182:6460-6469.
23. Edwards, J. L., and M. A. Apicella. 2004. The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin. Microbiol. Rev. 17:965-981.
24. Fairley, C. K., L. Gurrin, J. Walker, and J. S. Hocking. 2007. " Doctor, how long has my Chlamydia been there?" Answer: " years". Sex. Transm. Dis. 34:727-728.
25. Feinen, B., A. E. Jerse, S. L. Gaffen, and M. W. Russell. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucosal. Immunol. 3:312-321.
26. Fukata, M., and M. T. Abreu. 2007. TLR4 signalling in the intestine in health and disease. Biochem. Soc. Trans. 35:1473-1478.
27. Gilbert, D. N., R. C. Moellering, G. M. Ellopoulos, and M. A. Sande. 2007. The Sanford guide to antimicrobial therapy 2007, 37th ed. Antimicrobial Therapy, Inc., Sperryville, VA.
28. Hook, E. W., and H. H. Handsfield. 1999. Gonococcal infections in the adult, p. 451-466. In K. K. Holmes, et al. (ed.), Sexually transmitted diseases, 3rd ed. McGraw-Hill Book Co., New York, NY.
29. Horne, A. W., S. J. Stock, and A. E. King. 2008. Innate immunity and disorders of the female reproductive tract. Reproduction 135:739-749.
30. -/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 48:4498-4508.
31. Imarai, M., et al. 2008. Regulatory T cells are locally induced during intravaginal infection of mice with Neisseria gonorrhoeae. Infect. Immun. 76:5456-5465.
32. Jerse, A. E. 1999. Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect. Immun. 67:5699-5708.
33. Jerse, A. E., et al. 1994. Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J. Exp. Med. 179:911-920.
34. Jerse, A. E., et al. 2003. A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection. Infect. Immun. 71:5576-5582.
35. Johnson, A. P., M. Tuffrey, and D. Taylor-Robinson. 1989. Resistance of mice to genital infection with Neisseria gonorrhoeae. J. Med. Microbiol. 30:33-36.
36. Kallstrom, H., M. K. Liszewski, J. P. Atkinson, and A. B. Jonsson. 1997. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 25:639-647.
37. Kellogg, D. S., Jr., W. L. Peacock, Jr., W. E. Deacon, L. Brown, and D. I. Pirkle. 1963. Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. J. Bacteriol. 85:1274-1279.
38. Kelly, K. A., et al. 2001. Chlamydia trachomatis infection does not enhance local cellular immunity against concurrent Candida vaginal infection. Infect. Immun. 69:3451-3454.
39. Kelly, K. A., E. A. Robinson, and R. G. Rank. 1996. Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection. Infect. Immun. 64:4976-4983.
40. Kilian, M., J. Mestecky, and M. W. Russell. 1988. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol. Rev. 52:296-303.
41. Kita, E., H. Matsuura, and S. Kashiba. 1981. A mouse model for the study of gonococcal genital infection. J. Infect. Dis. 143:67-70.
42. Kolls, J. K., P. B. McCray, Jr., and Y. R. Chan. 2008. Cytokine-mediated regulation of antimicrobial proteins. Nat. Rev. Immunol. 8:829-835.
43. Lee, B. C., and A. B. Schryvers. 1988. Specificity of the lactoferrin and transferrin receptors in Neisseria gonorrhoeae. Mol. Microbiol. 2:827-829.
44. Lentsch, A. B., H. Yoshidome, R. L. Warner, P. A. Ward, and M. J. Edwards. 1999. Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion. Gastroenterology 117:953-961.
45. Lin, J. S., et al. 1998. Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partners. J. Infect. Dis. 178:1707-1712.
46. Lycke, E., G. B. Lowhagen, G. Hallhagen, G. Johannisson, and K. Ramstedt. 1980. The risk of transmission of genital Chlamydia trachomatis infection is less than that of genital Neisseria gonorrhoeae infection. Sex. Transm. Dis. 7:6-10.
47. Makepeace, B. L., P. J. Watt, J. E. Heckels, and M. Christodoulides. 2001. Interactions of Neisseria gonorrhoeae with mature human macrophage opacity proteins influence production of proinflammatory cytokines. Infect. Immun. 69:1909-1913.
48. Matondo, P., I. Johnson, and S. Sivapalan. 1995. Epidemiology and transmission patterns of concomitant genital chlamydial and gonococcal infections. Genitourin. Med. 71:266-267.
49. McGowin, C. L., R. A. Spagnuolo, and R. B. Pyles. Mycoplasma genitalium rapidly disseminates to the upper reproductive tracts and knees of female mice following vaginal inoculation. Infect. Immun. 78:726-736.
50. Miller, W. C., et al. 2004. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 291:2229-2236.
51. Morioka, Y., K. Yamasaki, D. Leung, and R. L. Gallo. 2008. Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis. J. Immunol. 181:3915-3922.
52. Mrkic, B., et al. 1998. Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72:7420-7427.
53. Murakami, M., T. Ohtake, R. A. Dorschner, and R. L. Gallo. 2002. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J. Dent. Res. 81:845-850.
54. Ngampasutadol, J., et al. 2008. Species-specificity of Neisseria gonorrhoeae infection: do human complement regulators contribute? Vaccine 26(Suppl. 8):I62-I66.
55. Nsuami, M., C. L. Cammarata, B. N. Brooks, S. N. Taylor, and D. H. Martin. 2004. Chlamydia and gonorrhea co-occurrence in a high school population. Sex. Transm. Dis. 31:424-427.
56. O'Connell, C. M., R. R. Ingalls, C. W. Andrews, Jr., A. M. Scurlock, and T. Darville. 2007. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J. Immunol. 179:4027- 4034.
57. O'Connell, C. M., and K. M. Nicks. 2006. A plasmid-cured Chlamydia muridarum strain displays altered plaque morphology and reduced infectivity in cell culture. Microbiology 152:1601-1607.
58. Packiam, M., S. J. Veit, D. J. Anderson, R. R. Ingalls, and A. E. Jerse. Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses. Infect. Immun. 78:433-440.
59. Packiam, M., S. J. Veit, N. Mavrogiorgos, A. E. Jerse, and R. R. Ingalls. 2010. Protective and immunoregulatory role of Toll-like receptor 4 in experimental gonococcal infection of female mice. International Pathogenic Neisseria Conference, Banff, Alberta, Canada.
60. Pal, S., T. J. Fielder, E. M. Peterson, and L. M. de la Maza. 1993. Analysis of the immune response in mice following intrauterine infection with the Chlamydia trachomatis mouse pneumonitis biovar. Infect. Immun. 61:772-776.
61. Parr, M. B., et al. 1994. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab. Invest. 70:369-380.
62. Rank, R. G. 1994. Animal models for urogenital infections. Methods Enzymol. 235:83-93.
63. Rank, R. G., K. H. Ramsey, E. A. Pack, and D. M. Williams. 1992. Effect of gamma interferon on resolution of murine chlamydial genital infection. Infect. Immun. 60:4427-4429.
64. Rank, R. G., J. Whittimore, A. K. Bowlin, S. Dessus-Babus, and P. B. Wyrick. 2008. Chlamydiae and polymorphonuclear leukocytes: unlikely allies in the spread of chlamydial infection. FEMS Immunol. Med. Microbiol. 54:104-113.
65. Rasmussen, S. J., et al. 1997. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Invest. 99:77-87.
66. Reddy, B. S., et al. 2004. Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women: implication for T-cell responses. Clin. Exp. Immunol. 137:552-558.
67. Robertson, J. N., M. E. Ward, D. Conway, and E. O. Caul. 1987. Chlamydial and gonococcal antibodies in sera of infertile women with tubal obstruction. J. Clin. Pathol. 40:377-383.
68. Rosenvinge, M. M., and R. Lau. 2009. Screening for asymptomatic chlamydia in women: how often would gonorrhoea be missed? Int. J. STD AIDS 20:571-572.
69. Roshick, C., H. Wood, H. D. Caldwell, and G. McClarty. 2006. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect. Immun. 74:225-238.
70. Russell, M., et al. 2010. Infectivity acts as in vivo selection for maintenance of the chlamydial " cryptic" plasmid. Infect. Immun. 79:98-107.
71. Ryley, J. F., and S. McGregor. 1986. Quantification of vaginal Candida albicans infections in rodents. J. Med. Vet. Mycol. 24:455-460.
72. Shafer, W. M., X. Qu, A. J. Waring, and R. I. Lehrer. 1998. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. U. S. A. 95:1829-1833.
73. Simms, A. N., and A. E. Jerse. 2006. In vivo selection for Neisseria gonorrhoeae opacity protein expression in the absence of human carcinoembryonic antigen cell adhesion molecules. Infect. Immun. 74:2965-2974.
74. Soboll, G., T. M. Schaefer, and C. R. Wira. 2006. Effect of Toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse. Am. J. Reprod. Immunol. 55:434-446.
75. Soler-Garcia, A. A., and A. E. Jerse. 2007. Neisseria gonorrhoeae catalase is not required for experimental genital tract infection despite the induction of a localized neutrophil response. Infect. Immun. 75:2225-2233.
76. Song, W., et al. 2008. Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17(-estradioltreated mice. Vaccine 26:5741-5751.
77. Sonoda, Y., et al. 1998. Physiologic regulation of postovulatory neutrophil migration into vagina in mice by a C-X-C chemokine(s). J. Immunol. 160: 6159-6165.
78. Stamm, W. E. 1999. Chlamydia trachomatis infections of the adult, p. 407- 422. In K. K. Holmes, et al. (ed.), Sexually transmitted diseases, 3rd ed. McGraw-Hill Book Co., New York, NY.
79. Tuffrey, M., P. Falder, and D. Taylor-Robinson. 1982. Genital-tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis. Br. J. Exp. Pathol. 63:539-546.
80. Virji, M., et al. 1999. Critical determinants of host receptor targeting by Neisseria meningitidis and Neisseria gonorrhoeae: identification of Opa adhesiotopes on the N-domain of CD66 molecules. Mol. Microbiol. 34:538-551.
81. Warner, D. M., J. P. Folster, W. M. Shafer, and A. E. Jerse. 2007. Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae. J. Infect. Dis. 196:1804-1812.
82. Warner, D. M., W. M. Shafer, and A. E. Jerse. 2008. Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrDMtrE efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol. Microbiol. 70:462-478.
83. Wolf, K., G. V. Plano, and K. A. Fields. 2009. A protein secreted by the respiratory pathogen Chlamydia pneumoniae impairs IL-17 signaling via interaction with human Act1. Cell. Microbiol. 11:769-779.
84. Wu, H., and A. E. Jerse. 2006. Alpha-2,3-sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection. Infect. Immun. 74:4094-4103.
85. Wu, H., A. A. Soler-Garcia, and A. E. Jerse. 2009. A strain-specific catalase mutation and mutation of the metal-binding transporter gene mntC attenuate Neisseria gonorrhoeae in vivo but not by increasing susceptibility to oxidative killing by phagocytes. Infect. Immun. 77:1091-1102.
86. Yu, J. J., and S. L. Gaffen. 2008. Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front. Biosci. 13:170-177.